Data demonstrates 'efficacy and tolerability' of IDegLira

Diabetes Care has published phase IIIa findings that demonstrate a significantly greater glucose-lowering effect with IDegLira compared with insulin degludec.

Source: Pharmacy Europe - August 11, 2014 Category: Drugs & Pharmacology Authors: AMcculloch Tags: *** Editor's Pick Diabetes IDegLira insulin degludec/liraglutide Latest News type 2 diabetes Xultophy Source Type: news